Your point about the US effectively funding pharma research for the whole world is well taken (I think it's often kinda ignored by a lot of people), but the bil

Your point about the US effectively funding pharma research for the whole world is well taken (I think it's often kinda ignored by a lot of people), but the billing complexity is not inherent to healthcare—it's a result of the system, so I don't think it stands as an argument. Also, while drug costs can be explained, there are a lot of other costs in the system that are not necessarily affected by that argument (for instance, for a surgery, how much of the cost is actually due to said drugs, and how much is due to all the other factors?)